T

TriSalus Life Sciences Inc
NASDAQ:TLSI

Watchlist Manager
TriSalus Life Sciences Inc
NASDAQ:TLSI
Watchlist
Price: 7.51 USD 1.21% Market Closed
Market Cap: 375.2m USD
Section:
 

Relative Value

The Relative Value of one TLSI stock under the Base Case scenario is 6.15 USD. Compared to the current market price of 7.51 USD, TriSalus Life Sciences Inc is Overvalued by 18%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TLSI Relative Value
Base Case
6.15 USD
Overvaluation 18%
Relative Value
Price
T
Worst Case
Base Case
Best Case

Valuation Multiples

9.3
P/S
P/S
Price to Sales
9.3
vs History
18
vs Industry
28
Median 3Y
5.4
Median 5Y
3.8
Industry
2
Forward
8.2
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
4
Median 3Y
-3.7
Median 5Y
-3.8
Industry
18.2
Forward
-4.7
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-4.9
Median 5Y
-16.7
Industry
11.1
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-9.9
Median 5Y
-28.1
Industry
14.3
More Details
Negative
P/B
P/B
Price to Book Value
N/A
vs History
vs Industry
3
Median 3Y
-6.2
Median 5Y
-1.7
Industry
1.7
More Details
9.6
EV/S
EV/S
Enterprise Value to Sales
9.6
vs History
16
vs Industry
30
Median 3Y
5.7
Median 5Y
4.1
Industry
3.1
Forward
8.4
More Details
11.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
11.4
vs History
15
vs Industry
39
Median 3Y
6.7
Median 5Y
4.7
Industry
6.8
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-5.8
Median 5Y
-19.6
Industry
11
Forward
-20.7
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-5.7
Median 5Y
-19.1
Industry
13.3
Forward
-13.7
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-5.3
Median 5Y
-17.1
Industry
11.3
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-5.2
Median 5Y
-16.4
Industry
12.2
More Details
38.5
EV/IC
EV/IC
Enterprise Value to IC
38.5
vs History
0
vs Industry
9
Median 3Y
13.2
Median 5Y
8.2
Industry
1.7
More Details

Multiples Across Competitors

TLSI Competitors Multiples
TriSalus Life Sciences Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
TriSalus Life Sciences Inc
NASDAQ:TLSI
374.7m USD 9.3 -5.2 -12.6 -12.3
UK
Eight Capital Partners PLC
F:ECS
633.6T EUR 0 0 0 0
US
Suncast Solar Energy Inc
OTC:SUNC
513.9T USD 232 643 252.8 3 421 187 861.8 -615 404 093 -490 467 135.3
US
Music Licensing Inc
OTC:SONG
500.2B USD 3 881.3 -9 191.7 -9 231.3 -9 231.3
US
GE Vernova LLC
NYSE:GEV
178.9B USD 0 0 0 0
US
China Industrial Group Inc
OTC:CIND
121B USD 351.6 4 020.7 3 417.4 3 537.2
IN
SAB Industries Ltd
BSE:539112
8.9T INR 22 236.2 32 834.5 181 985.6 194 874.1
NL
Nepi Rockcastle NV
JSE:NRP
86.4B Zac 0 0 0 0
CH
Galderma Group AG
SIX:GALD
38.6B CHF 0 0 0 0
US
Reddit Inc
NYSE:RDDT
44.2B USD 23.2 126.7 150.5 159.7
US
Coupang Inc
F:788
35.8B EUR 1.2 107.7 28.8 47.3
P/S Multiple
Revenue Growth P/S to Growth
US
T
TriSalus Life Sciences Inc
NASDAQ:TLSI
Average P/S: 33 238 536.5
9.3
47%
0.2
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
S
Suncast Solar Energy Inc
OTC:SUNC
232 643 252.8
N/A N/A
US
Music Licensing Inc
OTC:SONG
3 881.3
N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
11%
N/A
US
C
China Industrial Group Inc
OTC:CIND
351.6
N/A N/A
IN
S
SAB Industries Ltd
BSE:539112
22 236.2
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
-3%
N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
17%
N/A
US
R
Reddit Inc
NYSE:RDDT
23.2
44%
0.5
US
Coupang Inc
F:788
1.2
16%
0.1
P/E Multiple
Earnings Growth PEG
US
T
TriSalus Life Sciences Inc
NASDAQ:TLSI
Average P/E: 684 244 990.3
Negative Multiple: -5.2 		N/A N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
S
Suncast Solar Energy Inc
OTC:SUNC
3 421 187 861.8
N/A N/A
US
Music Licensing Inc
OTC:SONG
Negative Multiple: -9 191.7 N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
49%
N/A
US
C
China Industrial Group Inc
OTC:CIND
4 020.7
N/A N/A
IN
S
SAB Industries Ltd
BSE:539112
32 834.5
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
-5%
N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
85%
N/A
US
R
Reddit Inc
NYSE:RDDT
126.7
N/A N/A
US
Coupang Inc
F:788
107.7
121%
0.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
T
TriSalus Life Sciences Inc
NASDAQ:TLSI
Average EV/EBITDA: 46 395.6
Negative Multiple: -12.6 		N/A N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
S
Suncast Solar Energy Inc
OTC:SUNC
Negative Multiple: -615 404 093 N/A N/A
US
Music Licensing Inc
OTC:SONG
Negative Multiple: -9 231.3 N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
53%
N/A
US
C
China Industrial Group Inc
OTC:CIND
3 417.4
N/A N/A
IN
S
SAB Industries Ltd
BSE:539112
181 985.6
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
-5%
N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
28%
N/A
US
R
Reddit Inc
NYSE:RDDT
150.5
N/A N/A
US
Coupang Inc
F:788
28.8
57%
0.5
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
T
TriSalus Life Sciences Inc
NASDAQ:TLSI
Average EV/EBIT: 49 654.6
Negative Multiple: -12.3 		N/A N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
S
Suncast Solar Energy Inc
OTC:SUNC
Negative Multiple: -490 467 135.3 N/A N/A
US
Music Licensing Inc
OTC:SONG
Negative Multiple: -9 231.3 N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
93%
N/A
US
C
China Industrial Group Inc
OTC:CIND
3 537.2
N/A N/A
IN
S
SAB Industries Ltd
BSE:539112
194 874.1
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
-1%
N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
39%
N/A
US
R
Reddit Inc
NYSE:RDDT
159.7
N/A N/A
US
Coupang Inc
F:788
47.3
78%
0.6

See Also

Summary
TLSI intrinsic value, competitors valuation, and company profile.
DCF Valuation
TLSI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TLSI stock valuation using valuation multiples.
Wall Street Estimates
TLSI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TLSI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 304,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.